Monument Therapeutics accesses £1.5m for schizophrenia clinical development
LONDON, UK: Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, announced that Monument Therapeutics Limited has completed...
GIP Australia Fund II raises A$4.0 billion for Australasian Ventures
Global Infrastructure Partners (GIP) has successfully closed its fundraising efforts for the GIP Australia Fund II (GIPA II), amassing A$4.0 billion in committed capital. This...
Amaroq Minerals to raise £30 million for Southern Greenland projects
Amaroq Minerals Ltd., a mining company with gold and energy transition mineral assets in Southern Greenland, announced its plan to raise £30 million (C$51 million...
Global Bioenergies completes €14.5 million fundraising
PARIS, FRANCE: Global Bioenergies announced successful completion of its capital increase for a total amount of €14.5 million, without preferential subscription rights for shareholders in favor of institutional investors for €13.5 million and of retail investors via the PrimaryBid platform for €1 million....
Chapel Down completion fundraising of £6.876 million
LONDON: Chapel Down Group, the market leader in English wines, announced the completion of the fundraising announced on 4 June 2021. The £6.876 million was...
AFC Energy expands partnership with ABB, announces £35 million fundraising
LONDON: AFC Energy plc announced the expansion of its existing strategic partnership with ABB through the signing of a new Development Agreement for the integration...